Zayna Khayat, PhD., MaRS, Canada

Similar documents
Centre for the Advancement of Health Innovations (CAHI)

Scottish Health and Life Sciences Innovation Workshop. The Industrial Strategy Challenge Fund

December Eucomed HTA Position Paper UK support from ABHI

Health Technology Assessment: What are the key challenges to assess medical devices? Rosanna Tarricone, PhD Director CERGAS Scientific Director EHTI

MedTech Europe position on future EU cooperation on Health Technology Assessment (21 March 2017)

Written Submission for the Pre-Budget Consultations in Advance of the 2019 Budget By: The Danish Life Sciences Forum

Reduce cost sharing and fees Include other services. Services: which services are covered? Population: who is covered?

Convergence and Differentiation within the Framework of European Scientific and Technical Cooperation on HTA

Horizon Societal Challenge 1: Health, demographic change and wellbeing. Jeremy Bray DG Research & Innovation European Commission

Advances and Perspectives in Health Information Standards

HTA Position Paper. The International Network of Agencies for Health Technology Assessment (INAHTA) defines HTA as:

How can public and social innovation build a more inclusive economy?

Patient safety and optimal performance:

Health Innovation Manchester

Centre for Healthcare Technologies

executives are often viewed to better understand the merits of scientific over commercial solutions.

SMART PLACES WHAT. WHY. HOW.

FDA Centers of Excellence in Regulatory and Information Sciences

Evidence Standards and AI

Digital Identity Innovation Canada s Opportunity to Lead the World. Digital ID and Authentication Council of Canada Pre-Budget Submission

Health Technology Assessment and the European Network for HTA

Exploratory Process on the Future of the Medical Devices

Early HTA to inform value driven market access and reimbursement planning

Science, technology and engineering for innovation and capacity-building in education and research UNCTAD Wednesday, 28 November 2007

Medical Device Industry in India

Innovation in HTA: What is the additional value?

IP and Technology Management for Universities

CDP-EIF ITAtech Equity Platform

Smart cities: A human-centered approach Engineering and Construction Conference June 20 22, 2018

Digitising European Industry: A key role for Digital Innovation Hubs in the regions

Andalusian Agency for Health Technology Assessment (AETSA)

Changing Healthcare Procurement Approaches in Canada and Beyond

Financing the Technology Innovation of SMEs in Korea. Hong Jae-Keun (Ph.D)

STI for reducing inequality within and among countries (SDG 10)

OCHIS: Catalyst for Collaboration and Commercialization

EU s Innovative Medical Technology and EMA s Measures

EHR Optimization: Why Is Meaningful Use So Difficult?

Fostering SME innovation through cross-border cooperation

Medicines Manufacturing in the UK 2017

Innovation & health connected. Business plan summary

Health Technology Assessment of Medical Devices in Low and Middle Income countries: challenges and opportunities

Advancing Health and Prosperity. A Brief to the Advisory Panel on Healthcare Innovation

Health & Social Care Industrial Innovation

A Focus on Health Data Infrastructure, Capacity and Application of Outcomes Data

WORLD ANGEL INVESTMENT SUMMIT

EPSRC Funding for Engineering

Q&A with Samira Salman

ABHI Response to the Kennedy short study on Valuing Innovation

An Introduction to China s Science and Technology Policy

(Fig.) JPMA Industry Vision 2025

Technology and Innovation in the NHS Scottish Health Innovations Ltd

Discovery: From Concept to the Patient - The Business of Medical Discovery. Todd Sherer, Ph.D.

@piret.tonurist o e. c d / o p s O P S I g o v o p s o e c d. o r g

Research Development Request - Profile Template. European Commission

Future City Glasgow. City of Glasgow

2. Evidence themes and their importance along the development path

ONTARIO CENTRES OF EXCELLENCE OVERVIEW. Greater Peterborough Innovation Cluster Quarterly Membership Breakfast September 21, 2012

AGENDA. Whole Health Innovation Collaborative Meeting: Applying Precision to Preventative Health and Personalized Medicine

Overview of Health Technology Assessment (HTA) from Asia Pacific Perspective

Cross Linking Research and Education and Entrepreneurship

Sponsored by WIPO, JPO, and IPOPHL Manila, 29 February 2016

Christopher Kunney, CPHIT, MSMOT Executive Healthcare IT Strategist Phone: LinkedIn: Twitter:

Technology and Innovation in the NHS Highlands and Islands Enterprise

OPEN INNOVATION AS A STRATEGIC MODEL OF MODERN BUSINESS

A Science & Innovation Audit for the West Midlands

9 Vaccine SMEs' Needs

TWO BY TWO: A METHODOLOGICAL PERSPECTIVE ON THE USE OF EVIDENCE TO SUPPORT THE VALUE OF A HEALTH TECHNOLOGY

Adopting Standards For a Changing Health Environment

Collaborating with the Office of Technology Transfer

KIC EIT Raw Materials

Technology Leadership Course Descriptions

Converting Research into Innovation & Growth: SBIR, the University, and the Park

Building global engagement in research Sources of funding for enabling international research collaborations

RIS3 from Strategic Orientations towards Policy Implementation: The Challenges Claire NAUWELAERS Independent expert in STI policy

INNOVATION PERFORMANCE REVIEW OF ARMENIA Chapter 2: National Innovation System and Innovation Governance

Driving Innovation. Connect and Catalyse. Medicines and Healthcare the Global perspective (+10 years) Zahid Latif

Biomedical Innovation Has Science Overtaken the System?

SUTTER HEALTH: A HEALTH DATA SHARING CASE STUDY

WORLD ANGEL INVESTMENT SUMMIT

Role of Public funding in Enhancing Innovation

Finding Common Ground Webinar: Learning from the Ontario Tender Fruit Lab

INNOVATION, HEALTH AND WEALTH ACCELERATING THE ADOPTION AND DIFFUSION IN THE NHS. MELANIE OGDEN DEPUTY DIRECTOR OF INNOVATION October 2013

Helping your business grow in the UK health system

Internationalisation of STI

Corporate slide master

Business angels Published on Innovation Policy Platform (

Wolfpack Investor Network. Investing in Our University s Best and Brightest

University IP and Technology Management. University IP and Technology Management

Shared Investment. Shared Success. ReMAP Call for Proposals by Expression of Interest

COURSE SCHEDULE

WHY FORM THE HEALTH CARE TEACHING COUNTY PARTNERSHIP?

British Business Bank

Engineering Change Lab (Eng Lab) UNLOCKING THE POTENTIAL OF THE ENGINEERING PROFESSION IN CANADA SYSTEMICALLY, EXPERIMENTALLY & COLLABORATIVELY

Translational scientist competency profile

Medtronic Payer Solutions

INNOVATION SCALE-UP POLICY: ACCESS AND OPPORTUNITY

Final Pitch Competition PROGRAM GUIDE. Wednesday, March 2, 2016 at HIMSS16 VENETIAN - PALAZZO - SANDS EXPO CENTER LEVEL 3 - LIDO 3104 LAS VEGAS, NV

REGIONAL INTELLIGENCE FOR REGIONAL STRATEGY. Dr. James Wilson Orkestra and Deusto Business School

Digital Masterplanning Steve Turner, Arup

Achievements of FP7 examples that make us proud

Transcription:

Zayna Khayat, PhD., MaRS, Canada MaRSMission: improve public health & Improve health system performance, & drive the new health economy Senior Advisor, Director of EXCITE program pre-market health technology evaluation Adjunct professor, Health strategy, RotmanSchool of Management, U. of Toronto Health and Life Science consulting - Boston Consulting Group & KPMG

Developing talent Growing ventures Opening markets Ensuringwide scale adoption of precision medicine technologies Zayna Khayat, Ph.D. @ZaynaKhayat @MaRSDD zkhayat@marsdd.com SEPTEMBER 19, 2015 Visit us at marsdd.com

Health Energy & Environment Finance & Commerce Work & Learning 9/26/2016

The Future of Health 1. Timing Today: System Reactive, delayed, sick care Future: Citizen Anticipatory, predictive 2. Tailoring 3. Modality 1 size fits all [none] Institution-centred Individualized,configurable,precise Dephysicalized, Digi-cal 4. Duration 5. Power 6. Biz Model Episodic, intermittent, silo d Provider Volume-based Continuous, team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 4

Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Outdated regul n Today: System Push vs. pull Infrastructure Procurement/diffusion Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 5 Developing talent Growing ventures Opening markets

Invention + Adoption = Innovation Invention Adoption

Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Innovation capacity Outdated regul n Procurement Push instead of pull Infrastructure Procurement Push instead of / diffusion pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 7 Developing talent Growing ventures Opening markets

Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity 1. Innovation capacity Outdated regul n Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 8

9/26/2016

The problem:incumbent institutions largely designed to stifle innovation Zayna Khayat MaRS Discovery District (2016) 10

Corporate vs. Startup A permanent organization designed to execute a repeatable and scalable business model A temporary organization designed to search for a repeatable and scalable business model Source: Steve Blank Zayna Khayat MaRS Discovery District (2016) 11

MaRS Corporate Innovation Platform Roland Harwood, Open Innovation (2014) (Reproduced) Zayna Khayat MaRS Discovery District (2016) 12

Corporate Innovation Partners

Health Innovation Centre Meetup (Hosted by MaRS)

40,000 square feet @ MaRS 50-70 health startups incubated Rx + med tech + digital health + consumer Access to J&J global networks No strings attached model

Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement 2. Push instead of pull Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 16

Hurdles to full value capture from med tech Patients accessing technology (+ Obsolescence of old) Developing talent Growing ventures Opening markets 1. Evidence 6. Adoption 2. Licensing 3. HTA, Coverage decision 4. Funding, fee codes 5. Procurement Time Visit us at marsdd.com

Pull model for innovation U Pre-Market Post-Market Diffusion E f f e c t i v Effectiveness e n e s s Systematic review Systematic review Cost Effectiveness Cost Effectiveness (CE) Obsolescence Efficacy Safety Value (CE) Affordability Ethical & societal Post-market conditions Efficacy Safety Value (CE) Affordability Ethical & societal Post-market conditions Yes Unconditional No TIME Regulation Reimbursement Zayna Khayat MaRS Discovery District (2016) 18

EXCELLENCE IN CLINICAL INNOVATION & TECHNOLOGY EVALUATION Health System Regulators + 24 research hospitals + >30 community health orgs Academic HTA + 15 others Industry Zayna Khayat MaRS Discovery District (2016) 19

P R E L I M I N A R Y EXCITE International: Extending the model globally International Board International Scientific Collaboration Develop accepted frameworks to assist EXCITE International affiliates in their work EXCITE INTERNATIONAL SECRETARIAT International Leadership Centres Coordinates multinational evaluations for MNEs and SMEs Facilitates MC quality frameworks Advises/assists members in setting up local EXCITE like operations EXCITE International Affiliates CANADA(MARS) US UK NL NZ Others

Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Visit us at marsdd.com Innovation capacity Procurement Infrastructure 3. Push Procurement instead of / pull diffusion Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 21 Developing talent Growing ventures Opening markets

Exponential tech. Linear health system Time to reach 50 M users 17 yrs Average time from evidence to practice in medicine: 17 years Vala Afshar; Citi Digital Strategy Team; Michael Felton, The New York Times (in HBR.org) 22

REACH: Outcomes-based procurement Resources for Evaluating, Adopting and Capitalizing on Innovative Healthcare Technology A program to help Ontario healthcare providers use new ways to evaluate, buy and more rapidly adopt beneficial medical technologies addressing highpriority health system problems. REACH will provide a pathway for innovative technologies to earn access to the Ontario market. Zayna Khayat MaRS Discovery District (2016) 23

Procurement by Co-Design Program $50K to help health organizations buy innovative med tech INITIATION DESIGN & PROTOTYPE 10 weeks 32 weeks Provider Challenge Briefs Design Discovery Vendor Innovator Briefs Vendor Selection Prototype $25K PROCURE Procurement voucher $25K Evaluate Final evaluation Zayna Khayat MaRS Discovery District (2016) 24

Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models 4. Information asymmetry Fragmentation / lack of scale Incentives/payment schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 25

Information Asymmetry Source: Lucien Engelen, Radboud Medical University Centre (Netherlands) Zayna Khayat MaRS Discovery District (2016) 26

Data Everywhere Developing talent Growing ventures Opening markets Medical record = Phenome Visit us at marsdd.com Source: Exponential Medicine 2015 Zayna Khayat MaRS Discovery District (2016) 27

MyHealth: Data flows to/thru Patient Zayna Khayat MaRS Discovery District (2016) Source: Lucien Engelen, Radboud Medical University Centre (Netherlands) 28

Outdated regul n Today: System Reactive, sick care 1 size fits all [none] Institution-centred Episodic, intermittent, silo d Provider Volume-based Innovation capacity Procurement Infrastructure Push instead of pull Consumer User Payer Outdated delivery models Information asymmetry Fragmentation / lack of scale 5. Incentives/payment schemes schemes Future: Citizen Anticipatory, proactive, predictive Individualized,precise Dephysicalized, Digi-cal Continuous team People-powered Outcomes-based Zayna Khayat MaRS Discovery District (2016) 29

HowGoogleWorks.Net Zayna Khayat MaRS Discovery District (2016) 30

Buying outcomes, not products Value = Outcomes Costs All or some portion of payment made to a product or service provider is contingent on meeting a set of results Zayna Khayat MaRS Discovery District (2016) 31

New outcomes financing vehicles Social impact bond in hypertension Intermediary Investor(s) Success payments Capital investment Service provider Success payments Outcomes payer Health intervention Target population Outcome measures Evaluator

Developing talent Growing ventures Opening markets Invention + Adoption = Innovation Visit us at marsdd.com

KEEP CALM & KEEP INNOVATING Developing talent Growing ventures Opening markets Zayna Khayat, Ph.D. MaRS Health zkhayat@marsdd.com @ZaynaKhayat INNOVATION B ECAUSE THE FUTURE MAT TERS Visit us at marsdd.com Zayna Khayat MaRS Discovery District (2016) 34